Concepedia

Reynalda deJesus

RD

6

Publications

207

Citations

6

H-Index

1991

Active since

Affiliations

Novartis (Switzerland)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Reynalda deJesus is an author at Novartis (Switzerland) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1991–2017

6

Publications

6

Dicarboxylic Acid Dipeptide Neutral Endopeptidase Inhibitors

Gary M. Ksander, Raj D. Ghai, Reynalda deJesus et al. · Journal of Medicinal Chemistry · 1995 · 81 citations · Full text

, , +14

Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines

John E. Francis, Randy L. Webb, Geetha Ghai et al. · Journal of Medicinal Chemistry · 1991 · 44 citations · Full text

Diaminoindanes as Microsomal Triglyceride Transfer Protein Inhibitors

Gary M. Ksander, Reynalda deJesus, Andrew Yuan et al. · Journal of Medicinal Chemistry · 2001 · 32 citations · Full text

, , +12

Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists

Alexander Pasternak, Stephen D. Goble, Reynalda deJesus et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 22 citations · Full text

, , +4

The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes

Shuwen He, Zhixiong Ye, Quang Truong et al. · ACS Medicinal Chemistry Letters · 2012 · 18 citations · Full text

, , +18

Rows per page

1–5 of 6